UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by EverSource Wealth Advisors LLC

EverSource Wealth Advisors LLC boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 24.9% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,606 shares of the healthcare conglomerate's stock after purchasing an additional 719 shares during the quarter. EverSource Wealth Advisors LLC's holdings in UnitedHealth Group were worth $1,824,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of UNH. NewSquare Capital LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at $25,000. AlphaMark Advisors LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at $30,000. Promus Capital LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at $32,000. RPg Family Wealth Advisory LLC purchased a new position in shares of UnitedHealth Group in the 3rd quarter valued at $37,000. Finally, Pillar Financial Advisors LLC purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at $40,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of analysts have recently weighed in on UNH shares. Hsbc Global Res raised UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research report on Friday, January 10th. KeyCorp reissued an "overweight" rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Piper Sandler lowered their price objective on UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a research report on Thursday, January 2nd. Barclays lowered their price objective on UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating for the company in a research report on Friday, January 17th. Finally, HSBC raised UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price target for the company in a research report on Friday, January 10th. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat, UnitedHealth Group currently has a consensus rating of "Buy" and an average price target of $629.32.

Remove Ads

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction dated Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock traded down $0.32 on Thursday, hitting $480.79. The company's stock had a trading volume of 2,876,610 shares, compared to its average volume of 4,922,227. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The firm has a fifty day moving average price of $511.85 and a 200-day moving average price of $551.01. The company has a market capitalization of $439.78 billion, a price-to-earnings ratio of 31.02, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the previous year, the business earned $5.83 EPS. UnitedHealth Group's revenue for the quarter was up 6.8% compared to the same quarter last year. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be paid a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, March 10th. This represents a $8.40 annualized dividend and a yield of 1.75%. UnitedHealth Group's dividend payout ratio (DPR) is currently 54.19%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.